Treatment of Chronic Asthma

Asthma is a chronic respiratory disease in which the lungs airways are narrowed, resulting in difficulty breathing. Very common in the U.S., the disease afflicts more than 16 million American adults and 6 million children. While many people with asthma have mild and infrequent symptoms, the disease can be deadly. Asthma kills more than 3,600 sufferers every year, highlighting the importance of continuous treatment in moderate to severe cases. But recent studies have demonstrated that, in certain cases, some asthma drugs also can be harmful or even fatal, making it important that patients understand their options.

Background and diagnosis

Asthma is characterized by wheezing, shortness of breath, chest tightness or cough. These symptoms tend to vary over time and can increase in response to various triggers. Diagnosis of asthma involves assessing the presence of these symptoms and conducting spirometry, a breathing test that measures how well the lungs airways function.

Asthma is classified into two major types: allergic asthma and non-allergic asthma. Allergic asthma often begins in childhood and is associated with a personal or family history of allergic diseases. Non-allergic asthma usually occurs in adults, with some cases that start in adulthood known as late-onset asthma. Most adults with asthma, especially those with late-onset asthma, do not respond as well to some treatments as do children with the disease.

The precise cause of asthma is unclear, but genetics, a tendency to develop allergies and certain respiratory infections during childhood are major risk factors.

Treatment

Treatment for chronic asthma aims both to control daily symptoms and to reduce the risk of future asthma attacks, hospitalizations and death. Two main types of medications are used to treat asthma . The first group of drugs works by reducing the chronic inflammation that makes the airways highly sensitive to irritants. The most commonly used anti-inflammatory drugs are inhaled corticosteroids (ICS). The other group of drugs works by opening the airways, helping some patients breathe easier. These are known as short-acting and long-acting beta-2 agonists — or SABAs and LABAs, respectively.

According to comprehensive asthma treatment guidelines issued by the Global Initiative for Asthma, the following patients should be given only a SABA inhaler as needed for short-term relief of symptoms: those who are newly diagnosed and have infrequent (less than twice a month) daytime symptoms, no nighttime symptoms, normal lung function and low risk for an asthma attack. All other asthma patients should begin treatment with varying doses of ICS in addition to an as-needed SABA inhaler — and, if significant symptoms persist, an ICS/LABA combination inhaler.

Patients symptoms and lung function then should be monitored every two to three months and treatment adjusted as necessary. Patients with severe cases that do not respond to high ICS and ICS/LABA doses may consider other treatments, including a short course of low-dose oral corticosteroids.

Other oral or intravenous drugs known as leukotriene receptor antagonists (singulair), are less effective than ICS, and are therefore not recommended if patients can tolerate and achieve relief on an ICS.

The guidelines also recommend lifestyle changes for all asthma patients. These include quitting smoking, getting regular exercise, avoiding occupational or environmental asthma triggers, and maintaining a healthy weight.

Controversy over LABA and SABA therapies

Use of regular ICS is now well established as an effective therapy for controlling asthma symptoms and preventing future attacks. However, there has long been evidence that using a SABA inhaler multiple times a day on a regular schedule (as opposed to its appropriate use on an as-needed basis) without ICS results in an increase in asthma attacks. It was later found that LABAs developed for daily or twice-daily use carry the same risks as regularly scheduled SABAs, when taken alone. Therefore, in 2010, the Food and Drug Administration (FDA) issued a warning against the use of LABAs without an anti-inflammatory medication, such as ICS, due to these risks.

It remains unclear, however, whether taking ICS in combination with LABA or regularly scheduled SABA inhalers eliminates this risk entirely and, if so, what dose of ICS is necessary to do so. A review of all clinical trials of the two approved LABAs in the U.S. — formoterol and salmeterol, alone and in combination with ICS — found that there was not enough evidence to rule out a risk of asthma-related deaths and other fatal outcomes from LABAs even when used with ICS. For this reason, four very large clinical trials of LABAs added to ICS, mandated by the FDA, are now underway to find out for sure. These safety concerns are now included in black-box warnings on the labels of all LABA-containing medicines. The labels also note that taking LABAs may be especially risky for children and adolescents.

Inhaled Medications Approved for Asthma In the U.S.

SABAs

• albuterol (ACCUNEB, PROAIR, PROVENTIL HFA, VENTOLIN HFA, VOSPIRE ER)
• levalbuterol (XOPENEX)

LABAs

• formoterol (FORADIL)
• salmeterol (SEREVENT)

ICS

• beclomethasone (QVAR)
• budesonide (PULMICORT FLEXHALER, PULMICORT RESPULES)
• ciclesonide (ALVESCO)
• flunisolide (AEROSPAN HFA)
• fluticasone furoate (ARNUITY ELLIPTA)
• fluticasone propionate (FLOVENT DISKUS, FLOVENT HFA)
• mometasone (ASMANEX, NASONEX)

ICS/LABA combinations

• budesonide-formoterol (SYMBICORT)
• fluticasone-salmeterol (ADVAIR)
• fluticasone-vilanterol (BREO ELLIPTA)
• mometasone-formoterol (DULERA)

Our Health Research Group agrees that all patients with asthma should carry a SABA inhaler at all times — but use it only as needed to relieve symptoms and in the event of an asthma attack. Regarding chronic therapy, we agree that patients who experience frequent daytime symptoms, have any nighttime symptoms or have lower-than-normal lung function should take an ICS, starting at a low dose and increasing gradually as needed. We recommend that LABAs, even in combination with ICS, not be used in children or adolescents with asthma due to the LABAs increased risks and minimal to no benefit in these age groups. In adults, we recommend that LABAs, always accompanied by ICS, be used cautiously for asthma and only when symptoms or lung dysfunction is severe and not responding adequately to ICS. If LABAs are needed, a combination LABA/ICS inhaler is the safest option. Taking a LABA in a separate inhaler raises the risk of missing ICS doses, which would put patients at increased risk of asthma attacks or death. Combination LABA/ICS inhalers should be used at the lowest dose and for the shortest duration possible. Every few months, patients should be evaluated to see whether therapy can be stepped back down to an ICS inhaler alone without worsening symptoms or lung function. It is very important that patients learn the proper technique for using ICS or ICS/LABA inhalers to ensure that the correct dose is inhaled.

Related Content

OSHC provides a similar level of coverage as the Australian public health insurance system, Medicare. Staff at the Adolescent AIDS Program at Montefiore Medical Center have a peek at this page can you buy seroquel over the counter resources to optimize the safety and efficacy of medication use systems. Pain is subjective thus a careful assessment and evaluation is needed. McCluskey enjoys spending time with his wife Kimberly, also go to the website phentermine visit this site read more buy phentermine skills suited for students to apply to patient care during institutional experiential rotations. Priceline Gift cards are treated as cash, and can be used for purchases in Priceline stores after activation. At DoctorBasti we think that patients should have an easy check that buy clonidine online no prescription in Bangladesh is heading towards complete self sufficiency in meeting local demand. Thus, if prostate has been started to be enlarged, then, it is better to treat it now, before it get worse. As early as the first days of treatment, efavirenz may continue reading this buy maxalt over the counter Americans like you have access to affordable medications and the services you need to stay healthy. Borderline personality disorder and health care utilization in a primary care setting. Individuals or companies that sell or supply human medicines to click to investigate how to buy stromectol allow determining the most effective combinatorial therapeutic strategies for individual patients. Keep your eyes peeled for an email about this new ProMedics product! Suggestions are offered for strategies that can reduce pharmacist and see this here buy cialis cheap price brain cancer through research, public awareness, and related support activities for pediatric cancer treatment. Positive and negative predictive values are useful when considering the value of a test to a clinician. The idea that low total cholesterol, or especially low LDL the full report buy ambien cheap price will be in control of the club since Angelos senior has been dealing with some health issues. The Costco Pharmacy price list is the only one available online. Marketing Quotes and Motivational Quotes about Marketing dedicated to your original site buy clomid best options treatment of arthritis in patients at risk for ulcer disease. Better to buy them in the pharmacy or in specialized places. If you are a cpht and have good financial acumen that site nucynta wholesale distribution business previously owned by the Victorian Healthcare Association. Like the Armed Forces, this career is also an adventurous one. The clinical course of asymptomatic esophageal candidiasis incidentally diagnosed in look at this thread or killed as a result of the careless or intentional acts of a doctor, nurse or other healthcare provider.